Vivek K. Vyas

Virtual Screening: A Fast Tool for Drug Design

Vivek K. Vyas · Scientia Pharmaceutica · 2008 · 94 citations · Full text

New Ligands, Drug Target, Hit Identification +17

Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives

Pavan Srivastava, Vivek K. Vyas, Bhavesh C. Variya et al. · Bioorganic Chemistry · 2016 · 93 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Anti-inflammatory +10

Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors

Vivek K. Vyas, Manjunath Ghate, Ashutosh Goel · Journal of Molecular Graphics and Modelling · 2013 · 68 citations

Virtual Screening, Engineering, Drug Target +9

Neuroprotective Effects of Ethyl Pyruvate against Aluminum Chloride-Induced Alzheimer’s Disease in Rats via Inhibiting Toll-Like Receptor 4

Vijaya Durga Chavali, Milee Agarwal, Vivek K. Vyas et al. · Journal of Molecular Neuroscience · 2020 · 45 citations

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +11

CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer

Dhara M. Chhatbar, Udit Chaube, Vivek K. Vyas et al. · Computational Biology and Chemistry · 2019 · 40 citations

Topomer Comfa, Medicinal Chemistry, Medicine +8